Product
SPYK04
1 clinical trial
1 indication
Indication
Metastatic Solid TumorsClinical trial
A Phase I, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of SPYK04 as Monotherapy in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2024-06-30